Home | About the eMC | Help | Mobile
eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Advanced search
Get Medicines Compendium UK app here

Allen & Hanburys Ltd
Stockley Park West, Uxbridge, Middlesex, UB11 1BT
Telephone: +44 (0)800 221 441
Fax: +44 (0)208 990 4328
Medical Information e-mail: customercontactuk@gsk.com

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Summary of Product Characteristics last updated on the eMC: 03/01/2012
SPC Ventolin Evohaler

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 03/01/2012 and displayed until Current
Reasons for adding or updating:
  • Change to section 4.1 - Therapeutic indications
  • Change to section 4.2 - Posology and method of administration
  • Change to section 5.1 - Pharmacodynamic Properties
  • Change to section 10 date of revision of the text
Updated on 20/07/2009 and displayed until 03/01/2012
Reasons for adding or updating:
  • Change to section 4.9 - Overdose
Updated on 25/09/2008 and displayed until 20/07/2009
Reasons for adding or updating:
  • Change to section 6. 4 - Special Precautions for Storage
  • Change to section 10 date of revision of the text
Updated on 11/07/2007 and displayed until 25/09/2008
Reasons for adding or updating:
  • Change to section 4.3 - Contraindications
  • Change to section 4.4 - Special warnings and precautions for Use
  • Change to section 4.8 - Undesirable Effects
  • Change to section 10 date of revision of the text
Updated on 16/03/2007 and displayed until 11/07/2007
Reasons for adding or updating:
  • Change to section 4.6 - Pregnancy and Lactation
  • Change to section 10 date of revision of the text
Updated on 24/04/2006 and displayed until 16/03/2007
Reasons for adding or updating:
  • Change to section 4.8 - Undesirable Effects
  • Change to section 10 (date of (partial) revision of the text
Updated on 11/11/2005 and displayed until 24/04/2006
Reasons for adding or updating:
  • Change to section 4.2 - Posology and Method of Administration
Updated on 28/04/2005 and displayed until 11/11/2005
Reasons for adding or updating:
  • Change to section 4.8 - Undesirable Effects
Updated on 05/08/2003 and displayed until 28/04/2005
Reasons for adding or updating:
  • Change to section 9 - Date of Renewal of Authorisation
Updated on 12/12/2002 and displayed until 05/08/2003
Reasons for adding or updating:
  • Removal of Black Triangle
Updated on 26/09/2002 and displayed until 12/12/2002
Reasons for adding or updating:
  • Removal of Black Triangle
Updated on 21/08/2001 and displayed until 26/09/2002
Reasons for adding or updating:
  • Transferred from eMC version 1
Updated on 11/08/2001 and displayed until 21/08/2001
Reasons for adding or updating:
  • Transferred from eMC version 1
Updated on 18/09/2000 and displayed until 11/08/2001
Reasons for adding or updating:
  • No reasons supplied
Updated on 06/09/1999 and displayed until 18/09/2000
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
  salbutamol sulphate